Related Articles
Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge
A peptide antigen derived from EGFR T790M is immunogenic in non‑small cell lung cancer
Dynamic monitoring of EGFR mutations in circulating cell-free DNA for EGFR-mutant metastatic patients with lung cancer: Early detection of drug resistance and prognostic significance
Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system
Performance of different methods for detecting T790M mutation in the plasma of patients with advanced NSCLC after developing resistance to first‑generation EGFR‑TKIs in a real‑world clinical setting